Test
|
Method / Pharmacopeia
|
Specification
|
| Physical Identity of product |
Visual |
Report Results |
| Foreign matter inspection |
Microscopy |
Absence of foreign materials |
| EP<2.8.2> |
| Total Moisture Content |
Loss on drying USP <921> |
Report Results |
| EP< 2.2.32> |
| Total Delta -9- Tetrahydrocannabinol (THC) content |
High Pressure Liquid Chromatography (HPLC) |
Report results |
| Total Cannabidiol (CBD) |
High Pressure Liquid Chromatography (HPLC) |
Report results |
| Pesticides |
Health Canada Protocol |
Health Canada Limits per the Cannabis Act |
| Arsenic |
EPA 200.2 / US EPA 200.8 / EP 2.4.20 |
<1.96 ppm |
| USP <232><233> |
<1.96 ppm |
| Mercury |
EPA 200.2 / US EPA 200.8 / EP 2.4.20 |
< 0.1 ppm |
| USP <232><233> |
<4.06 ppm |
| Lead |
EPA 200.2 / US EPA 200.8 / EP 2.4.20 |
< 5.0 ppm |
| USP <232><233> |
<1.96 ppm |
| Cadmium |
EPA 200.2 / US EPA 200.8 / EP 2.4.20 |
< 1.0 ppm |
| USP <232><233> |
<1.26 ppm |
| Aflatoxins (B1+B2+G1+G2) |
EP <2.8.18> |
< 4 ppb |
| USP <2021> |
< 20 ppb |
| Aflatoxin B1A |
EP <2.8.18> |
<2 ppb |
| USP <561> |
< 5 ppb |
| Total Aerobic Count |
EP <2.6.12> |
< 500,000 CFU/g |
| USP <2021> / USP <61> |
<100,000 CFU/g |
| Total Yeasts and Mold count |
EP <2.6.12> |
< 50,000 CFU/g |
| USP <2021>/ USP <61> |
<1000 CFU/g |
| Bile Tolerant bacteria |
EP <2.6.31> / EP <2.6.13> |
< 10,000 MPN/g |
| USP <2021>/ USP <61> |
< 1,000 MPN CFU/g |
| Escherichia coli |
EP <2.6.31> / EP <2.6.13> |
Absent in 1g |
| USP <2022>/ USP <62> |
Absent in 10g |
| Salmonella species |
EP <2.6.31> / EP <2.6.13> |
Absent in 25g |
| USP <2022> / USP <62> |
Absent in 10g |
